Amaero Posts 35% Q3 Revenue Growth, Guides Q4 to $4.5M-$5.0M
AMRO sits 80% above its 52-week low of $3.57 on light trading volume (0.3× avg).
Summary
Amaero reported Q3 2026 revenue of $4.1 million (up 35% year-over-year) and guided Q4 to $4.5 million-$5.0 million, implying full-year revenue of $16.0 million-$16.5 million. Offsetting the growth story: a $4.4 million gross loss on the titanium production restart and a $9.1 million net loss.
Key Events · Earnings and Guidance · AMRO
-
Q3 Revenue Up 35% to $4.1M
Revenue for the quarter ended September 30, 2026 was $4.1 million versus $3.1 million a year earlier; nine-month revenue reached $11.5 million, up 170% from $4.3 million.
-
First Q4 and FY2026 Revenue Guidance
Q4 2026 revenue guided to $4.5 million-$5.0 million (up 121%-146%), implying full-year 2026 revenue of $16.0 million-$16.5 million, up 154%-162% from $6.3 million in 2025.
-
Gross Loss of $4.4M on Titanium Restart
Cost of revenue of $8.5 million against $4.1 million of revenue produced a $4.4 million gross loss, as the six-week titanium production pause and sieving-system optimization reduced throughput and yields; net loss widened to $9.1 million ($0.38 per share).
-
Backlog of $13.4M, Up 96%
Backlog as of September 30, 2026 was $13.4 million, up 96% from $6.9 million at year-end 2025, including $4.4 million from the U.S. Department of War refractory alloy powder contract.
Analysis · AMRO · Manufacturing
Top-line momentum is clear in Amaero's first quarter as a Nasdaq-listed company: Q3 revenue of $4.1 million, up 35% year-over-year, and nine-month revenue of $11.5 million, up 170%, with backlog of $13.4 million providing visibility into the next twelve months. The bottom line is the problem. Cost of revenue of $8.5 million produced a $4.4 million gross loss as the titanium restart and new sieving system cut throughput and yields, and the net loss widened to $9.1 million from $4.1 million a year earlier. Management's inaugural Q4 guidance of $4.5 million to $5.0 million implies full-year revenue of $16.0 million to $16.5 million, up 154% to 162%, while the $17.0 million IPO plus the EXIM amendment leave $19.3 million of cash as of October 31, 2026. The thesis now hinges on whether that revenue converts into gross margin as the fixed cost base stays flat — the company says it does not expect fixed production costs to grow in proportion to revenue.
How filings like this one have moved
In the 30 days to Nov 9, 2026, 36.6% of the 2965 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AMRO was trading at $6.42 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $183.2M. The 52-week trading range was $3.57 to $8.64. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.